Betaplus Pharma SA
11.3 FTEThe score of Betaplus Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +5 % Equity +21 % Total assets +19 % Headcount (avg FTE) -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Betaplus Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €5.41m | ||||
| Net result | €1.27m | ||||
| Equity | €22.3m | ||||
| Cash | 14,655 € | ||||
| EBITDA | €1.47m | ||||
| Total assets | €24.9m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Aug 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 15 Nov 2022
Betaplus Pharma's financial analysis
- Solvency89.8%sector median: 52.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Betaplus Pharma
Betaplus Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.037.369
- VAT number
- BE0479037369
- Peppol
- Registered · 0208:0479037369 · as of 01 Nov 2026
- Legal form
- SA
- Incorporated
- 16 Dec 2002
- Registered office
- 1200 Woluwe-Saint-Lambert
- Size
- Small · 11.3 FTE
- Latest accounts
- 2025 · filed on 03 Aug 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Betaplus Pharma (SA) has been based in Woluwe-Saint-Lambert since 2002, active in: manufacture of basic pharmaceutical products. For 2025, it reports revenue of €5.41m, a net profit of €1.27m and equity of €22.3m. With 11.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 89.8%, above the median of its sector (52.1%).
Companies similar to Betaplus Pharma
Companies in the same business, of comparable size and area, outside its group.
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
- Laboratoires Sterop Manufacture of pharmaceutical preparations Anderlecht · balance sheet €23.9m
- Laboratoria Qualiphar Manufacture of pharmaceutical preparations Bornem · balance sheet €50.8m
- Sanico Manufacture of pharmaceutical preparations Turnhout · balance sheet €24.2m
- Medgenix Benelux Manufacture of pharmaceutical preparations Wevelgem · balance sheet €39.4m
- V.M.D. Manufacture of pharmaceutical preparations Arendonk · balance sheet €28.5m
- Besins Manufacturing Belgium Manufacture of pharmaceutical preparations Ixelles · balance sheet €19.1m
- Buckman Laboratories Manufacture of other organic basic chemicals Ghent · balance sheet €28.2m
Frequently asked questions about Betaplus Pharma
What is the revenue of Betaplus Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Betaplus Pharma amounts to 5,412,070 €.
What is the VAT number of Betaplus Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0479037369 for Betaplus Pharma, if the company is VAT-registered. Its company number (CBE) is 0479.037.369.
Where is the registered office of Betaplus Pharma?
According to the CBE register, the registered office of Betaplus Pharma is in 1200 Woluwe-Saint-Lambert.
What is the equity of Betaplus Pharma?
At the close of the 2025 financial year, the equity of Betaplus Pharma amounts to 22,327,343 €, a solvency of 89.8% of total assets.
How many people work at Betaplus Pharma?
11.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Betaplus Pharma?
The register lists 6 active mandates at Betaplus Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Betaplus Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →